{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:14:37Z","timestamp":1792602877985,"version":"4.5.0"},"reference-count":242,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1004695"],"award-info":[{"award-number":["1004695"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1042589"],"award-info":[{"award-number":["1042589"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156693"],"award-info":[{"award-number":["1156693"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015969","name":"Fay Fuller Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cellsig.2021.109949","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:34:59Z","timestamp":1612834499000},"page":"109949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Sphingolipids as multifaceted mediators in ovarian cancer"],"prefix":"10.1016","volume":"81","author":[{"given":"MelissaR","family":"Pitman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Pitson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2021.109949_bb0005","series-title":"The World Ovarian Cancer Coalition","first-page":"1","article-title":"The World Ovarian Cancer Coalition Atlas: Global trends in incidence, mortality and survival","author":"Coalition","year":"2018"},{"issue":"10","key":"10.1016\/j.cellsig.2021.109949_bb0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0015","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2021.109949_bb0020","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"16","key":"10.1016\/j.cellsig.2021.109949_bb0025","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1158\/1078-0432.CCR-19-4121","article-title":"EVOLVE: a multicenter open-label single-arm clinical and translational phase II trial of cediranib plus olaparib for ovarian cancer after PARP inhibition progression","volume":"26","author":"Lheureux","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1470-2045(20)30142-X","article-title":"Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial","volume":"21","author":"Pfisterer","year":"2020","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"\u201cPlatinum resistant\u201d ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0045","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum. Pathol."},{"issue":"7353","key":"10.1016\/j.cellsig.2021.109949_bb0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"N. Cancer Genome Atlas Research","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006707","article-title":"The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples","volume":"13","author":"Penner-Goeke","year":"2017","journal-title":"PLoS Genet."},{"issue":"17","key":"10.1016\/j.cellsig.2021.109949_bb0060","doi-asserted-by":"crossref","first-page":"28769","DOI":"10.18632\/oncotarget.15673","article-title":"Unsuccessful mitosis in multicellular tumour spheroids","volume":"8","author":"Molla","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0075","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-19-2850","article-title":"The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: an analysis from the ovarian cancer cohort consortium (OC3)","volume":"80","author":"Trabert","year":"2020","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.cellsig.2021.109949_bb0080","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1158\/1078-0432.CCR-18-0784","article-title":"Consensus on molecular subtypes of high-grade serous ovarian carcinoma","volume":"24","author":"Chen","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0085","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.celrep.2017.02.049","article-title":"Progesterone prevents high-grade serous ovarian Cancer by inducing necroptosis of p53-defective fallopian tube epithelial cells","volume":"18","author":"Wu","year":"2017","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.cellsig.2021.109949_bb0090","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study","volume":"14","author":"Sieh","year":"2013","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0095","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1038\/s41598-017-17265-6","article-title":"The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2021.109949_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/CMO.S32813","article-title":"Hormone receptors in serous ovarian carcinoma: prognosis, pathogenesis, and treatment considerations","volume":"10","author":"Voutsadakis","year":"2016","journal-title":"Clin. Med. Insights Oncol."},{"issue":"16","key":"10.1016\/j.cellsig.2021.109949_bb0105","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx176","article-title":"Genomic rearrangement signatures and clinical outcomes in high-grade serous ovarian cancer","volume":"110","author":"Hillman","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cellsig.2021.109949_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fgene.2020.00219","article-title":"Clinical interest of combining transcriptomic and genomic signatures in high-grade serous ovarian cancer","volume":"11","author":"Kieffer","year":"2020","journal-title":"Front. Genet."},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0120","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S1470-2045(16)30108-5","article-title":"Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study","volume":"17","author":"Bagnoli","year":"2016","journal-title":"Lancet Oncol."},{"issue":"19","key":"10.1016\/j.cellsig.2021.109949_bb0125","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/1078-0432.CCR-18-3720","article-title":"Molecular classification of epithelial ovarian Cancer based on methylation profiling: evidence for survival heterogeneity","volume":"25","author":"Bodelon","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.cellsig.2021.109949_bb0130","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1158\/1078-0432.CCR-18-0042","article-title":"FDA approval summary: niraparib for the maintenance treatment of patients with recurrent ovarian cancer in response to platinum-based chemotherapy","volume":"24","author":"Ison","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2021.109949_bb0135","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3389\/fonc.2019.01289","article-title":"Genomic profile and BRCA-1 promoter methylation status in BRCA mutated ovarian Cancer: new insights in predictive biomarkers of Olaparib response","volume":"9","author":"Franzese","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"16","key":"10.1016\/j.cellsig.2021.109949_bb0150","doi-asserted-by":"crossref","first-page":"11144","DOI":"10.1016\/S0021-9258(19)49887-6","article-title":"Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver","volume":"267","author":"Mandon","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.cellsig.2021.109949_bb0155","doi-asserted-by":"crossref","first-page":"35642","DOI":"10.1074\/jbc.M205211200","article-title":"Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells","volume":"277","author":"Venkataraman","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.cellsig.2021.109949_bb0160","doi-asserted-by":"crossref","first-page":"22432","DOI":"10.1074\/jbc.272.36.22432","article-title":"Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide","volume":"272","author":"Michel","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00062752-200301000-00004","article-title":"Structure, organization, and function of glycosphingolipids in membrane","volume":"10","author":"Hakomori","year":"2003","journal-title":"Curr. Opin. Hematol."},{"issue":"26","key":"10.1016\/j.cellsig.2021.109949_bb0170","doi-asserted-by":"crossref","first-page":"23294","DOI":"10.1074\/jbc.M201535200","article-title":"Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization","volume":"277","author":"Sugiura","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"Pt 2","key":"10.1016\/j.cellsig.2021.109949_bb0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/bj3500429","article-title":"Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes","volume":"350","author":"Pitson","year":"2000","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0180","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1083\/jcb.200203123","article-title":"Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis","volume":"158","author":"Le Stunff","year":"2002","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0185","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/bbrc.1997.7993","article-title":"Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast","volume":"242","author":"Zhou","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"32","key":"10.1016\/j.cellsig.2021.109949_bb0190","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.R111.254359","article-title":"Many ceramides","volume":"286","author":"Hannun","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0195","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/BJ20111626","article-title":"Ceramide synthases at the Centre of sphingolipid metabolism and biology","volume":"441","author":"Mullen","year":"2012","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5650\/jos.57.293","article-title":"Metabolism of odd-numbered fatty acids and even-numbered fatty acids in mouse","volume":"57","author":"Gotoh","year":"2008","journal-title":"J. Oleo Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb0205","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1096\/fj.201902645R","article-title":"Biosynthesis of the anti-lipid-microdomain sphingoid base 4,14-sphingadiene by the ceramide desaturase FADS3","volume":"34","author":"Jojima","year":"2020","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0210","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1074\/jbc.AC119.011883","article-title":"FADS3 is a Delta14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome","volume":"295","author":"Karsai","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.cellsig.2021.109949_bb0215","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1111\/febs.12559","article-title":"Glycosphingolipids: synthesis and functions","volume":"280","author":"D\u2019Angelo","year":"2013","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yexcr.2015.02.025","article-title":"Revisiting the sphingolipid rheostat: evolving concepts in cancer therapy","volume":"333","author":"Newton","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"5913","key":"10.1016\/j.cellsig.2021.109949_bb0225","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1167449","article-title":"The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors","volume":"323","author":"Kawahara","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0230","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/s41598-018-23300-x","article-title":"MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells","volume":"8","author":"Kobayashi","year":"2018","journal-title":"Sci. Rep."},{"issue":"7677","key":"10.1016\/j.cellsig.2021.109949_bb0235","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature24053","article-title":"Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets","volume":"550","author":"Vu","year":"2017","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.cellsig.2021.109949_bb0240","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1074\/jbc.M109.064162","article-title":"Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2","volume":"285","author":"Takabe","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0245","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jcb.20127","article-title":"Structural and functional characteristics of S1P receptors","volume":"92","author":"Sanchez","year":"2004","journal-title":"J. Cell. Biochem."},{"issue":"562","key":"10.1016\/j.cellsig.2021.109949_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat6662","article-title":"Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter","volume":"12","author":"Kajimoto","year":"2019","journal-title":"Sci. Signal."},{"issue":"5945","key":"10.1016\/j.cellsig.2021.109949_bb0255","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"issue":"381","key":"10.1016\/j.cellsig.2021.109949_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaa4998","article-title":"Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation","volume":"8","author":"Panneer Selvam","year":"2015","journal-title":"Sci. Signal."},{"issue":"7301","key":"10.1016\/j.cellsig.2021.109949_bb0265","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2","volume":"465","author":"Alvarez","year":"2010","journal-title":"Nature"},{"issue":"40","key":"10.1016\/j.cellsig.2021.109949_bb0270","doi-asserted-by":"crossref","first-page":"64886","DOI":"10.18632\/oncotarget.11714","article-title":"An oncogenic role for sphingosine kinase 2","volume":"7","author":"Neubauer","year":"2016","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.cellsig.2021.109949_bb0275","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1038\/onc.2016.428","article-title":"CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1","volume":"36","author":"Zhu","year":"2017","journal-title":"Oncogene"},{"issue":"1\u20133","key":"10.1016\/j.cellsig.2021.109949_bb0280","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1388-1981(02)00142-7","article-title":"Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors","volume":"1582","author":"Siehler","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20133","key":"10.1016\/j.cellsig.2021.109949_bb0285","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbalip.2004.01.006","article-title":"Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy","volume":"1682","author":"Taha","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"5\u20136","key":"10.1016\/j.cellsig.2021.109949_bb0290","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ando.2019.06.003","article-title":"Sphingosine-1-phosphate (S1P) in ovarian physiology and disease","volume":"80","author":"Hernandez-Coronado","year":"2019","journal-title":"Ann. Endocrinol. (Paris)"},{"issue":"2\u20133","key":"10.1016\/j.cellsig.2021.109949_bb0295","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1388-1981(02)00333-5","article-title":"Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility","volume":"1585","author":"Tilly","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0300","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/molehr\/gaaa022","article-title":"Effect of sphingosine-1-phosphate on activation of dormant follicles in murine and human ovarian tissue","volume":"26","author":"Pors","year":"2020","journal-title":"Mol. Hum. Reprod."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0305","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.fertnstert.2014.05.040","article-title":"Sphingosine-1-phosphate suppresses cyclophosphamide induced follicle apoptosis in human fetal ovarian xenografts in nude mice","volume":"102","author":"Meng","year":"2014","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0310","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/humrep\/dey045","article-title":"Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure","volume":"33","author":"Pascuali","year":"2018","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb0315","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0005-2760(92)90184-W","volume":"1165","author":"Takamatsu","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajog.2008.04.009","article-title":"The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?","volume":"199","author":"Nossov","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cellsig.2021.109949_bb0325","doi-asserted-by":"crossref","first-page":"34684","DOI":"10.1038\/srep34684","article-title":"LC-MS based Sphingolipidomic study on A2780 human ovarian cancer cell line and its Taxol-resistant strain","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0330","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1055-9965.1185.13.7","article-title":"Lysophospholipids are potential biomarkers of ovarian cancer","volume":"13","author":"Sutphen","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0335","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1158\/1535-7163.MCT-08-0088","article-title":"S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells","volume":"7","author":"Wang","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0340","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2017.07.143","article-title":"Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer","volume":"147","author":"Knapp","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0345","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10495-006-5882-8","article-title":"Dihydroceramide hinders ceramide channel formation: implications on apoptosis","volume":"11","author":"Stiban","year":"2006","journal-title":"Apoptosis"},{"issue":"61","key":"10.1016\/j.cellsig.2021.109949_bb0350","doi-asserted-by":"crossref","first-page":"102912","DOI":"10.18632\/oncotarget.22076","article-title":"High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism","volume":"8","author":"Braicu","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0355","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41416-018-0270-z","article-title":"Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism","volume":"119","author":"Niemi","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010072","article-title":"Relative ratios enhance the diagnostic power of phospholipids in distinguishing benign and cancerous ovarian masses","volume":"12","author":"Yagi","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"29","key":"10.1016\/j.cellsig.2021.109949_bb0365","doi-asserted-by":"crossref","first-page":"46834","DOI":"10.18632\/oncotarget.11603","article-title":"Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0370","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s12551-017-0297-z","article-title":"The many faces (and phases) of ceramide and sphingomyelin I - single lipids","volume":"9","author":"Fanani","year":"2017","journal-title":"Biophys. Rev."},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0375","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1194\/jlr.M058750","article-title":"Regulation of mitochondrial ceramide distribution by members of the BCL-2 family","volume":"56","author":"Zhang","year":"2015","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0380","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1471-0528.2004.00142.x","article-title":"Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer","volume":"111","author":"Santin","year":"2004","journal-title":"BJOG"},{"issue":"12","key":"10.1016\/j.cellsig.2021.109949_bb0385","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.1801041","article-title":"Sialic acid-dependent inhibition of T cells by exosomal ganglioside GD3 in ovarian tumor microenvironments","volume":"201","author":"Shenoy","year":"2018","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.cellsig.2021.109949_bb0390","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1158\/0008-5472.CAN-11-2695","article-title":"Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer","volume":"72","author":"Webb","year":"2012","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.cellsig.2021.109949_bb0395","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1158\/1078-0432.CCR-15-2518","article-title":"VEGF potentiates GD3-mediated immunosuppression by human ovarian cancer cells","volume":"22","author":"Tiper","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.cellsig.2021.109949_bb0400","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.18632\/oncotarget.2373","article-title":"Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer","volume":"5","author":"Dobbin","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2021.109949_bb0405","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.csbj.2019.04.004","article-title":"Interrelations of sphingolipid and lysophosphatidate signaling with immune system in ovarian cancer","volume":"17","author":"Meshcheryakova","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb0410","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9440(10)63306-8","article-title":"Differential gene expression in ovarian carcinoma: identification of potential biomarkers","volume":"165","author":"Hibbs","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb0415","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.18632\/oncotarget.6703","article-title":"Sphingosine kinase 1 is required for TGF-beta mediated fibroblastto- myofibroblast differentiation in ovarian cancer","volume":"7","author":"Beach","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0420","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1349-7006.2012.02335.x","article-title":"Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells","volume":"103","author":"Yang","year":"2012","journal-title":"Cancer Sci."},{"issue":"18","key":"10.1016\/j.cellsig.2021.109949_bb0425","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1158\/0008-5472.CAN-17-0025","article-title":"CIB2 negatively regulates oncogenic signaling in ovarian cancer via sphingosine kinase 1","volume":"77","author":"Zhu","year":"2017","journal-title":"Cancer Res."},{"issue":"43","key":"10.1016\/j.cellsig.2021.109949_bb0430","doi-asserted-by":"crossref","first-page":"74947","DOI":"10.18632\/oncotarget.20471","article-title":"Sphingosine kinase 1\/sphingosine-1-phosphate (S1P)\/S1P receptor axis is involved in ovarian cancer angiogenesis","volume":"8","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0435","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1002\/jcp.27970","article-title":"High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer","volume":"234","author":"Sheng","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2021.109949_bb0440","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1476-4598-9-186","article-title":"Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry","volume":"9","author":"Liu","year":"2010","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0445","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00428-019-02728-0","article-title":"Histotype-specific analysis of acid ceramidase expression in ovarian cancer","volume":"476","author":"El-Balat","year":"2020","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0450","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/PGP.0b013e3182673982","article-title":"Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancer","volume":"32","author":"Hanker","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0455","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccr.2007.04.011","article-title":"Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs","volume":"11","author":"Swanton","year":"2007","journal-title":"Cancer Cell"},{"issue":"6968","key":"10.1016\/j.cellsig.2021.109949_bb0460","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature02188","article-title":"Molecular machinery for non-vesicular trafficking of ceramide","volume":"426","author":"Hanada","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010169","article-title":"Role of microRNAs as clinical cancer biomarkers for ovarian cancer: a short overview","volume":"9","author":"Staicu","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.cellsig.2021.109949_bb0470","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/carcin\/bgu130","article-title":"Exosome-derived miRNAs and ovarian carcinoma progression","volume":"35","author":"Vaksman","year":"2014","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb0475","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/IGC.0b013e3181a48cf9","article-title":"miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma","volume":"19","author":"Flavin","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"41","key":"10.1016\/j.cellsig.2021.109949_bb0480","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1523\/JNEUROSCI.3883-11.2011","article-title":"MicroRNA-137\/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer\u2019s disease","volume":"31","author":"Geekiyanage","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0485","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.3892\/mmr.2015.3827","article-title":"MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1","volume":"12","author":"Wen","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0490","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1757-2215-6-84","article-title":"MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1","volume":"6","author":"Zhang","year":"2013","journal-title":"J. Ovarian Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034546","article-title":"Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma","volume":"7","author":"Creighton","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0500","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1535370215605586","article-title":"Transforming growth factor-beta-sphingosine kinase 1\/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells","volume":"241","author":"Liu","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0505","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1159\/000495243","article-title":"SphK1\/S1P mediates PDGF-induced pulmonary arterial smooth muscle cell proliferation via miR-21\/BMPRII\/Id1 signaling pathway","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0510","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2008.08.036","article-title":"The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform","volume":"112","author":"Resnick","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0515","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cellsig.2021.109949_bb0520","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Yeung","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0525","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/ijmm_00000530","article-title":"MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein","volume":"26","author":"Lou","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb0530","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ygyno.2018.06.002","article-title":"Factors that influence survival in high-grade serous ovarian cancer: a complex relationship between molecular subtype, disease dissemination, and operability","volume":"150","author":"Torres","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0535","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1002\/jcb.28593","article-title":"Exosomal transfer of miR-124 inhibits normal fibroblasts to cancer-associated fibroblasts transition by targeting sphingosine kinase 1 in ovarian cancer","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0540","doi-asserted-by":"crossref","first-page":"9276","DOI":"10.1074\/jbc.M211529200","article-title":"Modulation of transforming growth factor-beta (TGF-beta) signaling by endogenous sphingolipid mediators","volume":"278","author":"Sato","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb0545","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajpath.2014.09.023","article-title":"Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors","volume":"185","author":"Xiu","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0550","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/emmm.201200244","article-title":"Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1\/sphingosine 1-phosphate signalling to regulate tumour metastasis","volume":"4","author":"Ponnusamy","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0555","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.20180765","article-title":"Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J. Exp. Med."},{"issue":"26","key":"10.1016\/j.cellsig.2021.109949_bb0560","doi-asserted-by":"crossref","first-page":"42262","DOI":"10.18632\/oncotarget.15040","article-title":"Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb0565","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10434-999-0373-0","article-title":"Markedly elevated levels of vascular endothelial growth factor in malignant ascites","volume":"6","author":"Zebrowski","year":"1999","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.cellsig.2021.109949_bb0570","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-016-0497-3","article-title":"Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?","volume":"15","author":"Bekes","year":"2016","journal-title":"Mol. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2021.109949_bb0575","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/ijgc-00009577-200602001-00029","article-title":"Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up","volume":"16","author":"Rudlowski","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3b","key":"10.1016\/j.cellsig.2021.109949_bb0580","first-page":"1973","article-title":"Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer","volume":"24","author":"Li","year":"2004","journal-title":"Anticancer Res."},{"issue":"26","key":"10.1016\/j.cellsig.2021.109949_bb0585","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.cellsig.2021.109949_bb0590","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.cellsig.2021.109949_bb0595","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1158\/1078-0432.CCR-16-2196","article-title":"Bevacizumab May differentially improve ovarian Cancer outcome in patients with proliferative and mesenchymal molecular subtypes","volume":"23","author":"Kommoss","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"55","key":"10.1016\/j.cellsig.2021.109949_bb0600","doi-asserted-by":"crossref","first-page":"30552","DOI":"10.18632\/oncotarget.25702","article-title":"The prognostic significance of high\/positive expression of tissue VEGF in ovarian cancer","volume":"9","author":"Guo","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0605","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.29362","article-title":"Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer","volume":"137","author":"Lee","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0610","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/bjc.2012.468","article-title":"VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2","volume":"107","author":"Gavalas","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0615","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4143\/crt.2018.508","article-title":"Development of web-based nomograms to predict treatment response and prognosis of epithelial ovarian cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030719","article-title":"Ovarian cancer, cancer stem cells and current treatment strategies: a potential role of magmas in the current treatment methods","volume":"9","author":"Ahmed","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0625","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/IGC.0b013e3181bda1cb","article-title":"Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma","volume":"20","author":"Labiche","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"24","key":"10.1016\/j.cellsig.2021.109949_bb0630","doi-asserted-by":"crossref","first-page":"18594","DOI":"10.1074\/jbc.M109.072801","article-title":"Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells","volume":"285","author":"Illuzzi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2021.109949_bb0635","first-page":"3573","article-title":"Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640","volume":"33","author":"White","year":"2013","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0640","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/1878-0261.12048","article-title":"NMR metabolomics highlights sphingosine kinase-1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells","volume":"11","author":"Bernacchioni","year":"2017","journal-title":"Mol. Oncol."},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0645","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1158\/0008-5472.CAN-11-3069","article-title":"Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer","volume":"72","author":"Heering","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2021.109949_bb0650","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1476-4598-9-145","article-title":"Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling","volume":"9","author":"Liu","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2021.109949_bb0655","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/OTT.S154378","article-title":"Transcriptional profiling of NCI\/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance","volume":"11","author":"Vert","year":"2018","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0660","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41467-019-09312-9","article-title":"Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer","volume":"10","author":"Christie","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080933","article-title":"Estrogen and EGFR pathways regulate notch signaling in opposing directions for multi-ciliogenesis in the fallopian tube","volume":"8","author":"Zhu","year":"2019","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.cellsig.2021.109949_bb0670","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.7150\/jca.30588","article-title":"Estradiol and progesterone induced differentiation and increased stemness gene expression of human fallopian tube epithelial cells","volume":"10","author":"Chang","year":"2019","journal-title":"J. Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0675","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/humrep\/13.11.3114","article-title":"Induction of a differentiated ciliated cell phenotype in primary cultures of fallopian tube epithelium","volume":"13","author":"Comer","year":"1998","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0680","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.trsl.2013.11.008","article-title":"Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation","volume":"163","author":"Luo","year":"2014","journal-title":"Transl. Res."},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0685","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.18632\/oncotarget.6943","article-title":"Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers","volume":"7","author":"Ciucci","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0690","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B","volume":"9","author":"Kastner","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2021.109949_bb0695","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.steroids.2016.09.004","article-title":"Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER\/PR target genes","volume":"114","author":"Diep","year":"2016","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0700","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbalip.2014.02.005","article-title":"Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen","volume":"1841","author":"Guo","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb0705","doi-asserted-by":"crossref","first-page":"E1110","DOI":"10.1152\/ajpendo.00373.2006","article-title":"Progesterone-induced sphingosine kinase-1 expression in the rat uterus during pregnancy and signaling consequences","volume":"292","author":"Jeng","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0710","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1095\/biolreprod.110.084152","article-title":"Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1","volume":"84","author":"Becker","year":"2011","journal-title":"Biol. Reprod."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0715","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1194\/jlr.M400423-JLR200","article-title":"Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor","volume":"46","author":"Budnik","year":"2005","journal-title":"J. Lipid Res."},{"issue":"15","key":"10.1016\/j.cellsig.2021.109949_bb0720","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1038\/sj.emboj.7600321","article-title":"PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate","volume":"23","author":"Pierre","year":"2004","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0725","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1210\/endo.137.6.8641202","article-title":"Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis","volume":"137","author":"Santana","year":"1996","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb0730","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1194\/jlr.M089714","article-title":"Multiple actions of doxorubicin on the sphingolipid network revealed by flux analysis","volume":"60","author":"Snider","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cellsig.2021.109949_bb0735","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbior.2014.11.001","article-title":"Sphingolipids in the DNA damage response","volume":"58","author":"Carroll","year":"2015","journal-title":"Adv. Biol. Regul."},{"issue":"54","key":"10.1016\/j.cellsig.2021.109949_bb0740","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.1038\/sj.onc.1207087","article-title":"Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis","volume":"22","author":"Vit","year":"2003","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.cellsig.2021.109949_bb0745","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/j.1460-2075.1996.tb00599.x","article-title":"Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis","volume":"15","author":"Jaffrezou","year":"1996","journal-title":"EMBO J."},{"issue":"16","key":"10.1016\/j.cellsig.2021.109949_bb0750","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1074\/jbc.M109.078121","article-title":"The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis","volume":"285","author":"Siskind","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0755","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1096\/fj.202000205R","article-title":"Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy","volume":"34","author":"Canals","year":"2020","journal-title":"FASEB J."},{"issue":"Pt 2","key":"10.1016\/j.cellsig.2021.109949_bb0760","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20031819","article-title":"Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and\/or mitochondria?","volume":"382","author":"Bionda","year":"2004","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0765","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2012.01.038","article-title":"Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis","volume":"148","author":"Chipuk","year":"2012","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0770","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1074\/jbc.M706115200","article-title":"Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels","volume":"283","author":"Siskind","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0775","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1194\/jlr.M700480-JLR200","article-title":"Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins","volume":"49","author":"Stiban","year":"2008","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb0780","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbamem.2014.11.018","article-title":"Very long chain ceramides interfere with C16-ceramide-induced channel formation: a plausible mechanism for regulating the initiation of intrinsic apoptosis","volume":"1848","author":"Stiban","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0785","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s10495-015-1124-2","article-title":"A novel cisplatin mediated apoptosis pathway is associated with acid sphingomyelinase and FAS proapoptotic protein activation in ovarian cancer","volume":"20","author":"Maurmann","year":"2015","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0790","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1038\/s41467-018-06650-y","article-title":"C16-ceramide is a natural regulatory ligand of p53 in cellular stress response","volume":"9","author":"Fekry","year":"2018","journal-title":"Nat. Commun."},{"issue":"45","key":"10.1016\/j.cellsig.2021.109949_bb0795","doi-asserted-by":"crossref","first-page":"35617","DOI":"10.1074\/jbc.M007346200","article-title":"Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex","volume":"275","author":"Bourbon","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.cellsig.2021.109949_bb0800","doi-asserted-by":"crossref","first-page":"14556","DOI":"10.1021\/bi981401i","article-title":"Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells","volume":"37","author":"Huwiler","year":"1998","journal-title":"Biochemistry"},{"issue":"3\u20134","key":"10.1016\/j.cellsig.2021.109949_bb0805","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000233248","article-title":"A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation","volume":"24","author":"Yin","year":"2009","journal-title":"Cell. Physiol. Biochem."},{"issue":"10","key":"10.1016\/j.cellsig.2021.109949_bb0810","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nchembio.1059","article-title":"Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy","volume":"8","author":"Sentelle","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0815","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1073\/pnas.92.5.1347","article-title":"Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest","volume":"92","author":"Dbaibo","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0820","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1096\/fj.08-120550","article-title":"Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling","volume":"23","author":"Mukhopadhyay","year":"2009","journal-title":"FASEB J."},{"issue":"29","key":"10.1016\/j.cellsig.2021.109949_bb0825","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.1074\/jbc.274.29.20296","article-title":"Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A","volume":"274","author":"Ruvolo","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0830","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.cdd.4401382","article-title":"Cathepsin D links TNF-induced acid sphingomyelinase to bid-mediated caspase-9 and -3 activation","volume":"11","author":"Heinrich","year":"2004","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0835","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbalip.2016.09.019","article-title":"Sphingolipids in mitochondria","volume":"1862","author":"Hernandez-Corbacho","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"21","key":"10.1016\/j.cellsig.2021.109949_bb0840","doi-asserted-by":"crossref","first-page":"15691","DOI":"10.1074\/jbc.M000280200","article-title":"Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells","volume":"275","author":"Cuvillier","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2021.109949_bb0845","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cellsig.2010.04.004","article-title":"Sphingosine and FTY720 directly bind pro-survival 14-3-3 proteins to regulate their function","volume":"22","author":"Woodcock","year":"2010","journal-title":"Cell. Signal."},{"issue":"2\u20133","key":"10.1016\/j.cellsig.2021.109949_bb0850","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1388-1981(02)00336-0","article-title":"Sphingosine in apoptosis signaling","volume":"1585","author":"Cuvillier","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.cellsig.2021.109949_bb0855","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1096\/fj.201701512RR","article-title":"A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest","volume":"32","author":"Samarani","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2021.109949_bb0860","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10616","article-title":"Intracellular sphingosine releases calcium from lysosomes","volume":"4","author":"Hoglinger","year":"2015","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0865","first-page":"10914","article-title":"Expression of TFEB in epithelial ovarian cancer and its role in autophagy","volume":"9","author":"Fu","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0870","first-page":"9104","article-title":"High expression of LAMP1 as a prognostic marker in patients with epithelial ovarian cancer","volume":"10","author":"Xu","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb0875","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4161\/auto.6.8.13614","article-title":"FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy","volume":"6","author":"Zhang","year":"2010","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0880","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3892\/mmr.2014.2664","article-title":"Upregulation of forkhead box O3 transcription is involved in C2-ceramide induced apoptosis and autophagy in ovarian cancer cells in vitro","volume":"10","author":"Jin","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0885","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.critrevonc.2010.05.003","article-title":"The role of hypoxia inducible factor-1alpha in gynecological cancer","volume":"78","author":"Seeber","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cellsig.2021.109949_bb0890","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2147\/OTT.S65373","article-title":"HIF1alpha is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD consortium","volume":"7","author":"Braicu","year":"2014","journal-title":"Onco Targets Ther."},{"issue":"10","key":"10.1016\/j.cellsig.2021.109949_bb0895","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.3390\/ijms131013264","article-title":"Over-expression of semaphorin4D, hypoxia-inducible factor-1alpha and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer","volume":"13","author":"Chen","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0900","first-page":"1661","article-title":"Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy","volume":"7","author":"Birner","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2021.109949_bb0905","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.48","article-title":"Reciprocal influence of the p53 and the hypoxic pathways","volume":"2","author":"Sermeus","year":"2011","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0910","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1074\/jbc.M708241200","article-title":"Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2","volume":"283","author":"Anelli","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb0915","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1541-7786.MCR-18-0409","article-title":"SPHK1 is a novel target of metformin in ovarian cancer","volume":"17","author":"Hart","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"20","key":"10.1016\/j.cellsig.2021.109949_bb0920","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1158\/0008-5472.CAN-08-0917","article-title":"Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells","volume":"68","author":"Ader","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb0925","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1096\/fj.201901734RR","article-title":"Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate","volume":"34","author":"Hait","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2021.109949_bb0930","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.13","article-title":"Essential role for SphK1\/S1P signaling to regulate hypoxia-inducible factor 2alpha expression and activity in cancer","volume":"5","author":"Bouquerel","year":"2016","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0935","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","article-title":"The role of cellular reactive oxygen species in cancer chemotherapy","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb0940","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.RES.0000253900.66640.34","article-title":"Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis","volume":"100","author":"Pchejetski","year":"2007","journal-title":"Circ. Res."},{"issue":"41","key":"10.1016\/j.cellsig.2021.109949_bb0945","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1038\/sj.onc.1209568","article-title":"TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis","volume":"25","author":"Dumitru","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb0950","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1074\/jbc.274.11.7190","article-title":"Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells","volume":"274","author":"Huwiler","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb0955","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/BJ20091589","article-title":"Dihydroceramide desaturase activity is modulated by oxidative stress","volume":"427","author":"Idkowiak-Baldys","year":"2010","journal-title":"Biochem. J."},{"issue":"44","key":"10.1016\/j.cellsig.2021.109949_bb0960","doi-asserted-by":"crossref","first-page":"38069","DOI":"10.1074\/jbc.M111.297994","article-title":"Dihydroceramide-based response to hypoxia","volume":"286","author":"Devlin","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0965","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1074\/jbc.M112.402719","article-title":"Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain","volume":"288","author":"Zigdon","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb0970","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061466","article-title":"Therapeutic targeting of collective invasion in ovarian cancer","volume":"20","author":"Moffitt","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2021.109949_bb0975","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1038\/cddiscovery.2015.1","article-title":"Sphingolipids modulate the epithelial-mesenchymal transition in cancer","volume":"1","author":"Levade","year":"2015","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb0980","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/15548627.2017.1291479","article-title":"SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1\/E-cadherin in hepatoma cells","volume":"13","author":"Liu","year":"2017","journal-title":"Autophagy"},{"issue":"39","key":"10.1016\/j.cellsig.2021.109949_bb0985","doi-asserted-by":"crossref","first-page":"63324","DOI":"10.18632\/oncotarget.11450","article-title":"Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7\/ syndecan-1\/TGF-beta autocrine loop","volume":"7","author":"Zeng","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.cellsig.2021.109949_bb0990","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1194\/jlr.M084202","article-title":"Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5","volume":"59","author":"Newcomb","year":"2018","journal-title":"J. Lipid Res."},{"issue":"16","key":"10.1016\/j.cellsig.2021.109949_bb0995","doi-asserted-by":"crossref","first-page":"22295","DOI":"10.18632\/oncotarget.7947","article-title":"Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach","volume":"7","author":"Meshcheryakova","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb1000","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/onc.2014.55","article-title":"Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility","volume":"34","author":"Edmond","year":"2015","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb1005","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jcb.24716","article-title":"Silencing of LASS2\/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell","volume":"115","author":"Xu","year":"2014","journal-title":"J. Cell. Biochem."},{"issue":"21","key":"10.1016\/j.cellsig.2021.109949_bb1010","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1038\/onc.2015.330","article-title":"Ceramide limits phosphatidylinositol-3-kinase C2beta-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid","volume":"35","author":"Kitatani","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb1015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2015.05.009","article-title":"Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-alpha and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer","volume":"138","author":"Kolomeyevskaya","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"18","key":"10.1016\/j.cellsig.2021.109949_bb1020","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1128\/MCB.00465-08","article-title":"Filamin A links sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 at lamellipodia to orchestrate cell migration","volume":"28","author":"Maceyka","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2021.109949_bb1025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbalip.2009.01.019","article-title":"Galpha(q)-mediated plasma membrane translocation of sphingosine kinase-1 and cross-activation of S1P receptors","volume":"1791","author":"ter Braak","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb1030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2007.02.112","article-title":"S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells","volume":"356","author":"Park","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb1035","doi-asserted-by":"crossref","first-page":"9076","DOI":"10.1038\/s41598-017-08880-4","article-title":"Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells","volume":"7","author":"Ahn","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb1040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/cb5008426","article-title":"Drugging sphingosine kinases","volume":"10","author":"Santos","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb1045","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1194\/jlr.M049759","article-title":"Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II","volume":"55","author":"Cingolani","year":"2014","journal-title":"J. Lipid Res."},{"issue":"13","key":"10.1016\/j.cellsig.2021.109949_bb1050","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.18632\/oncotarget.7693","article-title":"Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells","volume":"7","author":"McNaughton","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.cellsig.2021.109949_bb1055","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1158\/1535-7163.MCT-15-0279","article-title":"The sphingosine kinase 2 inhibitor ABC294640 reduces the growth of prostate cancer cells and results in accumulation of dihydroceramides in vitro and in vivo","volume":"14","author":"Venant","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb1060","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1210\/en.2010-0420","article-title":"Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640","volume":"151","author":"Antoon","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellsig.2021.109949_bb1065","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.2147\/OTT.S208519","article-title":"Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo","volume":"12","author":"Song","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb1070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.109.163444","article-title":"Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2","volume":"333","author":"French","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb1075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.27706","article-title":"Metformin intake is associated with better survival in ovarian cancer: a case-control study","volume":"119","author":"Kumar","year":"2013","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb1080","article-title":"Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer","volume":"5","author":"Brown","year":"2020","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.cellsig.2021.109949_bb1085","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1535-7163.MCT-17-0927","article-title":"Metformin suppresses tumor progression by inactivating stromal fibroblasts in ovarian cancer","volume":"17","author":"Xu","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2021.109949_bb1090","first-page":"5879","article-title":"Sphingosine kinase 1 inhibition decreases the epithelial-mesenchymal transition and ameliorates renal fibrosis via modulating NF-kappaB signaling","volume":"11","author":"He","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb1095","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1074\/jbc.272.3.1682","article-title":"Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells","volume":"272","author":"Lavie","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb1100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bjc.1995.59","article-title":"Interaction of tamoxifen with the multidrug resistance P-glycoprotein","volume":"71","author":"Callaghan","year":"1995","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2021.109949_bb1105","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1073\/pnas.96.8.4432","article-title":"Tamoxifen inhibits acidification in cells independent of the estrogen receptor","volume":"96","author":"Altan","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"26","key":"10.1016\/j.cellsig.2021.109949_bb1110","doi-asserted-by":"crossref","first-page":"18364","DOI":"10.1074\/jbc.274.26.18364","article-title":"A mechanism for tamoxifen-mediated inhibition of acidification","volume":"274","author":"Chen","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cellsig.2021.109949_bb1115","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bbalip.2013.07.016","article-title":"Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells","volume":"1831","author":"Morad","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2021.109949_bb1120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.biopha.2016.04.016","article-title":"Effects of chemotherapy agents on Sphingosine-1-phosphate receptors expression in MCF-7 mammary cancer cells","volume":"81","author":"Ghosal","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.cellsig.2021.109949_bb1125","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1158\/1078-0432.CCR-07-4973","article-title":"Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles","volume":"14","author":"Devalapally","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.109949_bb1130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2006.02.023","article-title":"Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages","volume":"9","author":"Visentin","year":"2006","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb1135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cncr.30393","article-title":"A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma","volume":"123","author":"Pal","year":"2017","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.cellsig.2021.109949_bb1140","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/156652412803833599","article-title":"Molecular targets of FTY720 (fingolimod)","volume":"12","author":"Pitman","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.cellsig.2021.109949_bb1145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2018.08.015","article-title":"FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer","volume":"436","author":"Kreitzburg","year":"2018","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.cellsig.2021.109949_bb1150","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb1155","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1158\/1535-7163.MCT-19-0366","article-title":"Ceramide-rubusoside nanomicelles, a potential therapeutic approach to target cancers carrying p53 missense mutations","volume":"19","author":"Khiste","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb1160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1535-7163.MCT-17-0173","article-title":"Ceramide nanoliposomes as a MLKL-dependent, necroptosis-inducing, chemotherapeutic reagent in ovarian cancer","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2021.109949_bb1165","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1158\/1078-0432.CCR-04-1770","article-title":"Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma","volume":"11","author":"Stover","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"6\u20137","key":"10.1016\/j.cellsig.2021.109949_bb1170","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1515\/hsz-2015-0129","article-title":"Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic","volume":"396","author":"Kester","year":"2015","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2021.109949_bb1175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/157015906776359568","article-title":"Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives","volume":"4","author":"Scripture","year":"2006","journal-title":"Curr. Neuropharmacol."},{"issue":"30","key":"10.1016\/j.cellsig.2021.109949_bb1180","doi-asserted-by":"crossref","first-page":"21082","DOI":"10.1074\/jbc.M114.569574","article-title":"The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1","volume":"289","author":"Janes","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.cellsig.2021.109949_bb1185","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1073\/pnas.1820466116","article-title":"Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb1190","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0021-9258(17)49922-4","article-title":"Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy","volume":"295","author":"Wang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2021.109949_bb1195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnmol.2015.00029","article-title":"Sphingosine kinase 2-deficiency mediated changes in spinal pain processing","volume":"8","author":"Canlas","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cellsig.2021.109949_bb1200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cca.2018.02.029","article-title":"Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer","volume":"481","author":"Kozar","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.cellsig.2021.109949_bb1205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.2016.435","article-title":"Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)","volume":"116","author":"Lindemann","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2021.109949_bb1210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2006.10.053","article-title":"Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)","volume":"105","author":"Wagner","year":"2007","journal-title":"Gynecol. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656821000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656821000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:01:44Z","timestamp":1760266904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656821000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":242,"alternative-id":["S0898656821000371"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2021.109949","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingolipids as multifaceted mediators in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2021.109949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109949"}}